The Jackson Laboratory completed the acquisition of New York Stem Cell Foundation.

The Jackson Laboratory, a nonprofit biomedical research institution with a National Cancer Institute-designated Cancer Center, completed the acquisition of New York Stem Cell Foundation, a nonprofit dedicated to advancing cures through stem cell research. Financial terms were not disclosed. "Bringing JAX and NYSCF together marks a turning point for biomedical research. By combining three powerful approaches — genomics, stem cell innovation, and data-driven AI — we are creating a platform that accelerates discovery from the very start of research and giving scientists stronger tools to turn early insights into breakthroughs for patients," Lon Cardon, JAX President and CEO.